Trial
NCT06736509
An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Axsome Therapeutics, Inc.
Collaborators
—
Condition
Agitation in Patients With Dementia of the Alzheimer's Type
Intervention
AXS-05 (dextromethorphan-bupropion)
Why stopped
Study AXS-05-AD-305 was terminated due to completion of overall program objectives.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-25